Philip Corser focuses his practice on global and UK corporate transactions. He has nearly 20 years’ experience acting on a wide range of complex public and private mergers and acquisitions, joint ventures, equity capital market transactions and solvent and insolvent restructurings. Philip provides comprehensive advice on private asset and share purchases, public takeovers, stock exchange listings, shareholders’ agreements, group reorganisations, securities regulations, listing, disclosure and reporting rules, corporate governance and company law.
Philip has a wealth of experience in a wide range of business areas, including in particular the healthcare, pharmaceutical, biotechnology, financial services and industrial sectors.
Advised ReNew Energy Global plc on various UK corporate matters as an English Nasdaq company
Advised Akari Therapeutics, Plc on equity lines and registered and unregistered offerings of Nasdaq-listed ADRs and warrants and various UK corporate matters as an English Nasdaq company
Advised Zura Bio Limited in connection with its agreement to a de-SPAC merger with JATT Acquisition Corp.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.